Cargando…
Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
Modern life styles have made cardiovascular disease the leading cause of morbidity and mortality worldwide. Although current treatments substantially ameliorate patients’ prognosis after MI, they cannot restore the affected tissue or entirely re-establish organ function. Therefore, the main goal of...
Autores principales: | Liehn, Elisa A, Radu, Eugen, Schuh, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782704/ https://www.ncbi.nlm.nih.gov/pubmed/23547962 http://dx.doi.org/10.2174/1574888X11308040003 |
Ejemplares similares
-
Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium
por: Kolossov, Eugen, et al.
Publicado: (2006) -
Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium
por: Jiang, Qin, et al.
Publicado: (2016) -
Repetitive transplantation of different cell types sequentially improves heart function after infarction
por: Alexander, Schuh, et al.
Publicado: (2012) -
Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
por: Gorbunov, Nikolai, et al.
Publicado: (2012) -
Biomechanical assessment of remote and postinfarction scar remodeling following myocardial infarction
por: Rusu, Mihaela, et al.
Publicado: (2019)